A Pilot Study of Mitoxantrone in Combination with Clofarabine (MITCL) in Children, Adolescents and Young Adults (CAYA) with Refractory/Relapsed Acute Leukemia

被引：0
|
作者：
Hochberg, Jessica C. [1 ]
Oesterheld, Javier [2 ]
Miitano, Olga [1 ]
Harrison, Lauren [1 ]
Cairo, Mitchell S. [1 ,3 ,4 ,5 ,6 ]
机构：
[1] New York Med Coll, Pediat, Valhalla, NY 10595 USA
[2] Levine Childrens Hosp, Pediat Blood & Marrow Transplantat, Charlotte, NC USA
[3] New York Med Coll, Pathol, Valhalla, NY 10595 USA
[4] New York Med Coll, Cell Biol & Anat, Valhalla, NY 10595 USA
[5] New York Med Coll, Microbiol & Immunol, Valhalla, NY 10595 USA
[6] New York Med Coll, Med, Valhalla, NY 10595 USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页数：3
相关论文
共 50 条
  • [21] A phase I study of clofarabine in combination with cyclophosphamide and etoposide: A new regimen in pediatric patients with refractory or relapsed acute leukemia
    Hijiya, N.
    Franklin, J.
    Rytting, M.
    Cooper, T.
    Chu, R.
    Barry, E.
    McCarthy, C.
    Abichandani, R.
    Carroll, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [22] The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leukemia
    Hochberg, Jessica
    Zahler, Stacey
    Geyer, Mark B.
    Chen, Nan
    Krajewski, Jennifer
    Harrison, Lauren
    Militano, Olga
    Ozkaynak, M. Fevzi
    Cheerva, Alexandra C.
    Talano, Julie
    Moore, Theodore B.
    Gillio, Alfred P.
    Walters, Mark C.
    Baxter-Lowe, Lee Ann
    Hamby, Carl
    Cairo, Mitchell S.
    BONE MARROW TRANSPLANTATION, 2019, 54 (02) : 226 - 235
  • [23] Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia
    Kantarjian, H
    Gandhi, V
    Cortes, J
    Verstovsek, S
    Du, M
    Garcia-Manero, G
    Giles, F
    Faderl, S
    O'Brien, S
    Jeha, S
    Davis, J
    Shaked, Z
    Craig, A
    Keating, M
    Plunkett, W
    Freireich, EJ
    BLOOD, 2003, 102 (07) : 2379 - 2386
  • [24] Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia
    Jeha, S
    Gaynon, PS
    Razzouk, BI
    Franklin, J
    Kadota, R
    Shen, V
    Litchtman-Jones, L
    Rytting, M
    Bomgaars, LR
    Rheingold, S
    Ritchey, K
    Albano, E
    Arceci, RJ
    Goldman, S
    Griffin, T
    Altman, A
    Gordon, B
    Steinherz, L
    Weitman, S
    Steinherz, P
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (12) : 1917 - 1923
  • [25] Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia
    Jeha, Sima
    Razzouk, Bassem
    Rytting, Michael
    Rheingold, Susan
    Albano, Edythe
    Kadota, Richard
    Luchtman-Jones, Lori
    Bomgaars, Lisa
    Gaynon, Paul
    Goldman, Stewart
    Ritchey, Kim
    Arceci, Robert
    Altman, Arnold
    Stine, Kimo
    Steinherz, Laurel
    Steinherz, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (26) : 4392 - 4397
  • [26] A Pilot Study of the Safety and Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Children, Adolescents and Young Adults (CAYA) with Steroid Refractory Acute Graft-Versus-Host Disease (AGVHD)
    Shah, Tishi
    Mehta, Brinda
    Abikoff, Cori
    Shi, Qiuhu
    Plumer, Trevor
    Morris, Erin
    Harrison, Lauren
    Cairo, Mitchell S.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S99 - S99
  • [27] Dose-reduced combination of mitoxantrone, etoposide, and cytarabine (miniMEC) for relapsed and refractory acute leukemia
    Yamamoto, Chihiro
    Ito, Shoko
    Mashima, Kiyomi
    Umino, Kento
    Minakata, Daisuke
    Yamasaki, Ryoko
    Kawasaki, Yasufumi
    Sugimoto, Miyuki
    Nakano, Hirofumi
    Ashizawa, Masahiro
    Okazuka, Kiyoshi
    Hatano, Kaoru
    Sato, Kazuya
    Oh, Lekuni
    Fujiwara, Shin-Ichiro
    Ohmine, Ken
    Suzuki, Takahiro
    Muroi, Kazuo
    Kanda, Yoshinobu
    LEUKEMIA & LYMPHOMA, 2016, 57 (11) : 2541 - 2547
  • [28] The Use of Clofarabine and Cytarabine Combination (CLARA) As Salvage Therapy for Relapsed and/or Refractory Acute Myeloid Leukemia (AML)
    Leung, Anskar Y. H.
    Tse, Eric
    Liu, Herman S. Y.
    Sim, Joycelyn
    Kho, Bonnie C. S.
    Yip, Sze-Fai
    Lee, Harold K. K.
    Kwong, Yok Lam
    BLOOD, 2012, 120 (21)
  • [29] The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leukemia
    Jessica Hochberg
    Stacey Zahler
    Mark B. Geyer
    Nan Chen
    Jennifer Krajewski
    Lauren Harrison
    Olga Militano
    M. Fevzi Ozkaynak
    Alexandra C. Cheerva
    Julie Talano
    Theodore B. Moore
    Alfred P. Gillio
    Mark C. Walters
    Lee Ann Baxter-Lowe
    Carl Hamby
    Mitchell S. Cairo
    Bone Marrow Transplantation, 2019, 54 : 226 - 235
  • [30] Safety, pharmacokinetics, and pharmacodynamics of panobinostat in children, adolescents, and young adults with relapsed acute myeloid leukemia
    Karol, Seth E.
    Cooper, Todd M.
    Mead, Paul E.
    Crews, Kristine R.
    Panetta, John C.
    Alexander, Thomas B.
    Taub, Jeffrey W.
    Lacayo, Norman J.
    Heym, Kenneth M.
    Kuo, Dennis J.
    Schiff, Deborah E.
    Bhojwani, Deepa
    Ge, Yubin
    Klco, Jeffery M.
    Ribeiro, Raul C.
    Inaba, Hiroto
    Pui, Ching-Hon
    Rubnitz, Jeffrey E.
    CANCER, 2020, 126 (21) : 4800 - 4805
12345